20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Globus Medical (GMED) operates in the MEDICAL DEVICES industry and is headquartered in Audubon, United States with about 6,000 employees. Its market capitalization is roughly $10 billion. In the fiscal year ended 2025-12-31, GMED reported $2.9B in revenue and $538M in net income.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
Interactive charts & full statements → Open the GMED valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $3.1B | $2.9B | $2.5B | $1.6B | $1.0B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | $434M | $386M | $331M | $288M | $254M |
| Gross Profit | $2.2B | $2.0B | $1.5B | $1.0B | $759M | $719M | $572M | $605M | $554M | $486M | $429M | $412M | $364M | $334M | $311M | $263M | $234M | $213M |
| Gross Margin % | 68.5% | 67.4% | 58.9% | 65.0% | 74.2% | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.7% | 76.6% | 76.9% | 80.5% | 79.2% | 81.3% | 83.6% |
| Operating Income (EBIT) | $667M | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M | $172M | $138M | $102M | $115M | $97M | $88M | $82M |
| Operating Margin % | 21.2% | 16.3% | 6.6% | 8.5% | 22.3% | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | 23.4% | 29.7% | 29.4% | 30.4% | 32.2% |
| Net Income | $536M | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | $69M | $74M | $61M | $54M | $49M |
| Net Margin % | 17.0% | 18.3% | 4.1% | 7.8% | 18.6% | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | 15.8% | 19.1% | 18.3% | 18.9% | 19.2% |
| EBITDA | — | $730M | $474M | $347M | $305M | $265M | $178M | $229M | $219M | $205M | $193M | $196M | $160M | $121M | $133M | $116M | $106M | $97M |
| Earnings Per Share (EPS) | $3.90 | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | $0.73 | $0.80 | $0.81 | $0.72 | $0.54 |
| Shares Outstanding (M) | — | 137M | 138M | 115M | 103M | 104M | 101M | 102M | 101M | 98M | 96M | 96M | 95M | 94M | 92M | 75M | 75M | 91M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $790M | $760M | $826M | $769M | $745M | $598M | $657M | $626M | $630M |
| Gross Profit | $548M | $526M | $595M | $487M | $497M | $403M | $394M | $355M | $370M |
| Gross Margin % | 69.4% | 69.2% | 72.0% | 63.3% | 66.6% | 67.3% | 59.9% | 56.8% | 58.7% |
| Operating Income (EBIT) | $196M | $164M | $172M | $135M | $76M | $97M | $60M | $48M | $50M |
| Operating Margin % | 24.8% | 21.5% | 20.8% | 17.6% | 10.2% | 16.2% | 9.2% | 7.7% | 7.9% |
| Net Income | $152M | $124M | $141M | $119M | $203M | $75M | $27M | $52M | $32M |
| Net Margin % | 19.2% | 16.4% | 17.0% | 15.5% | 27.2% | 12.6% | 4.0% | 8.3% | 5.0% |
| EBITDA | — | $227M | $244M | $215M | $193M | $164M | $145M | $116M | $126M |
| Earnings Per Share (EPS) | $1.10 | $0.90 | $1.02 | $0.88 | $1.49 | $0.54 | $0.19 | $0.38 | $0.23 |
| Shares Outstanding (M) | — | 138M | 137M | 135M | 136M | 140M | 140M | 138M | 137M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $911M | $753M | $521M | $243M | $178M | $276M | $199M | $172M | $182M | $160M | $172M | $122M | $79M | $93M | $77M | $76M | $71M | $32M |
| Capital Expenditures (CapEx) | $160M | $165M | $115M | $78M | $74M | $57M | $64M | $71M | $60M | $51M | $41M | $51M | $25M | $24M | $25M | $22M | $12M | $26M |
| Free Cash Flow (FCF) | $751M | $589M | $405M | $165M | $104M | $219M | $135M | $101M | $122M | $108M | $131M | $71M | $54M | $70M | $52M | $54M | $59M | $6M |
| FCF Margin % | 23.9% | 20.0% | 16.1% | 10.5% | 10.2% | 22.9% | 17.1% | 12.9% | 17.1% | 17.0% | 23.2% | 13.1% | 11.5% | 16.1% | 13.4% | 16.3% | 20.5% | 2.4% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $210M | $202M | $249M | $250M | $78M | $177M | $210M | $204M | $54M |
| Capital Expenditures (CapEx) | $33M | $40M | $56M | $31M | $52M | $41M | $17M | $42M | $28M |
| Free Cash Flow (FCF) | $177M | $163M | $192M | $219M | $26M | $136M | $193M | $162M | $26M |
| FCF Margin % | 22.4% | 21.4% | 23.3% | 28.5% | 3.5% | 22.8% | 29.4% | 25.8% | 4.2% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.5B | $5.3B | $5.3B | $5.1B | $2.1B | $2.0B | $1.7B | $1.5B | $1.3B | $1.1B | $928M | $834M | $704M | $566M | $447M | $329M | $267M |
| Cash & Cash Equivalents | $508M | $526M | $784M | $467M | $150M | $193M | $239M | $196M | $140M | $119M | $67M | $60M | $82M | $90M | $212M | $143M | $112M |
| Total Liabilities | $720M | $730M | $1.1B | $1.1B | $230M | $216M | $173M | $130M | $115M | $111M | $96M | $119M | $118M | $94M | $61M | $47M | $38M |
| Total Debt (Short + Long-Term) | — | $15M | $454M | $429M | $3M | $94M | $89M | $75M | $5M | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $5M |
| Total Shareholders' Equity | $4.8B | $4.6B | $4.2B | $4.0B | $1.8B | $1.7B | $1.5B | $1.4B | $1.2B | $968M | $832M | $715M | $585M | $472M | $387M | $282M | $228M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GMED viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms